AstraZeneca
benefitting from broad based diverse source of revenue strong commercial performance and financial execution in broad based diverse source of revenue reiterating guidance core to increase by a high single digit to low double digit | AstraZeneca
Company
Deck Type
Deck date
July 2023
Slide
5 of 44
Similar slides by AstraZeneca
Results
November 2023
Results
November 2023
Results
July 2023
Results
February 2023
Related slides by other companies
Investor Presentation
October 2023
SPAC
March 2021
SPAC
July 2019
SPAC
September 2021
Other recent decks by AstraZeneca
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io